Investment
Features
FeesSafety
Academy
More
Pluang+

Across Protocol's Solana bridge hit by attack; user funds remain safe, losses limited to relayer funds.

Market News
17 Jul 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Across Protocol confirmed an attack on its Solana bridge deployment, detected early July 17, leading to the disabling of Solana deposits as a precaution. User funds were not affected; only the relayer funds operated by Risk Labs are at risk. This incident highlights ongoing vulnerabilities in crypto bridges but shows Across's intent-based model helped contain losses. The team is investigating the cause and working with security experts, with a full report expected soon. Deposits on Solana remain paused until further notice.

More News

Goodfirms launches guide to build prediction marketplaces with 100+ vetted vendors and clear cost ranges.

Goodfirms launches guide to build prediction marketplaces with 100+ vetted vendors and clear cost ranges.

Goodfirms has introduced the Prediction Marketplace Platform Vendor Recipe, a comprehensive guide that maps over 100 verified vendors across 20 technology categories and four build phases, with costs ranging from $25,000 to over $2 million. This reso...

Others
Neutral
20 minutes ago
Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth

Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth

The global mass spectrometry market, valued at $6.68 billion in 2025, is projected to grow to $14.09 billion by 2035 at a CAGR of 7.74%. Growth is fueled by increased adoption in pharmaceutical manufacturing, biotechnology research, clinical diagnost...

Market News
Bullish
24 minutes ago
New report details 1,859 clinical-stage pharma and biotech deals since 2020 with financial terms and contract insights

New report details 1,859 clinical-stage pharma and biotech deals since 2020 with financial terms and contract insights

ResearchAndMarkets.com released a comprehensive report covering over 1,859 clinical-stage partnering deals in pharmaceuticals and biotechnology from 2020 to 2026. The report includes detailed financial terms such as upfront payments, milestones, and ...

Others
Neutral
32 minutes ago
Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth

Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth

The global cancer biomarkers market is projected to grow from $28.25 billion in 2026 to $54.48 billion by 2032, at an 11.6% CAGR. Growth is fueled by rising cancer rates, technological advances like multi-omics and AI integration, and increased deman...

Market News
Bullish
36 minutes ago
Datadog CEO Olivier Pomel sells 127,000 shares for $32.9 million.

Datadog CEO Olivier Pomel sells 127,000 shares for $32.9 million.

Datadog CEO Olivier Pomel has sold 127,000 shares of the company, generating $32.9 million from the sale. This move may indicate personal financial planning or portfolio diversification by the CEO. Investors might watch for any further insider sales ...

Market News
Bullish
50 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App